X4 Pharmaceuticals, Inc — Director's Dealing 2019

Jun 19, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: X4 Pharmaceuticals, Inc (XFOR)
CIK: 0001501697
Period of Report: 2019-06-17

Reporting Person: Russo Rene (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-17	Stock Option (right to buy)	$14.75	A	3427	Acquired	2029-06-17	Common Stock (3427)	Direct

Footnotes

F1: 8.3333% of the shares subject to the option shall vest on July 17, 2019, with the remainder vesting in equal monthly installments of 8.3333% of the shares subject to the option until the 12-month anniversary of the date of the grant (or, if earlier, the date of the Issuer's next annual meeting of stockholders following the date of the grant), subject to the Reporting Person continuing to provide service through each such date.